Zydus Cadila to make remdesivir

Indian drug-maker Zydus Cadila on Friday said it has signed an exclusive agreement with US’ Gilead Sciences Inc to manufacture and market remdesivir which has emerged as one of the most promising drug candidates in the treatment of Covid-19 patients.